20. Immunologic neuromuscular disorders.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MAI.2003.92PMID 12592311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

  2002cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS

  2001cited by this paper
• Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.

  2001cited by this paper
• Multiple sclerosis.

  2000cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper
• IFN-β-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-β-1b Therapeutic Effects in Multiple Sclerosis1

  2000cited by this paper
• Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.

  2000cited by this paper
• Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

  1999cited by this paper
• Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis.

  1998cited by this paper
• Axonal transection in the lesions of multiple sclerosis.

  1998cited by this paper
• Immunoglobulin therapy in inflammatory myopathies

  1998cited by this paper
• Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome

  1998cited by this paper
• The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients.

  1998cited by this paper
• Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

  1998cited by this paper
• Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

  1998cited by this paper
• High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.

  1998cited by this paper
• Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1b

  1997cited by this paper
• Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

  1997cited by this paper
• Treatment of inflammatory myopathies

  1997cited by this paper
• Altered intrathymic T‐cell repertoire in human myasthenia gravis

  1997cited by this paper
• Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis

  1997cited by this paper
• Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4 (cid:49) T cells via CD40 ligand

  1997cited by this paper
• Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

  1997cited by this paper
• Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

  1997cited by this paper
• Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the Disease

  1997cited by this paper
• Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

  1997cited by this paper
• Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.

  1997cited by this paper
• A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex

  1996cited by this paper
• Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.

  1996cited by this paper
• Defining the clinical course of multiple sclerosis

  1996cited by this paper
• Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis.

  1996cited by this paper
• Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis

  1996cited by this paper
• Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

  1996cited by this paper
• Long-term prognosis of 69 patients with dermatomyositis or polymyositis.

  1996cited by this paper
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

  1996cited by this paper
• Guillain-Barré syndrome: clinical neurophysiologic studies.

  1996cited by this paper
• AAEM minimonograph #25: Single‐fiber electromyography

  1996cited by this paper
• The prognosis and main prognostic indicators of Guillain-Barré syndrome. A multicentre prospective study of 297 patients. The Italian Guillain-Barré Study Group.

  1996cited by this paper
• Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.

  1995cited by this paper
• Inclusion body myositis and myopathies

  1995cited by this paper
• Associated autoimmune diseases in myasthenia gravis A population‐based study

  1995cited by this paper
• The adhesion molecule and cytokine profile of multiple sclerosis lesions

  1995cited by this paper
• Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

  1995cited by this paper
• Autonomic involvement in Guillain–Barre syndrome: A review

  1994cited by this paper
• Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.

  1994cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group.

  1993cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China

  1993cited by this paper
• Epidemiology of Multiple Sclerosis: A Critical Overview

  1993cited by this paper
• Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

  1993cited by this paper
• Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis.

  1992cited by this paper
• Polymyositis mediated by T lymphocytes that express the gamma/delta receptor.

  1991cited by this paper
• Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients.

  1991cited by this paper
• Polymyositis Mediated by T Lymphocytes That Express the γ/δ Receptor

  1991cited by this paper
• T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

  1990cited by this paper
• Seronegative myasthenia gravis

  1988cited by this paper
• Exacerbations of multiple sclerosis in patients treated with gamma interferon.

  1987cited by this paper
• Exacerbations of multiple sclerosis in patients treated with gamma interferon

  1987cited by this paper
• A population-based study of multiple sclerosis in twins.

  1986cited by this paper
• Microvascular deposition of complement membrane attack complex in dermatomyositis.

  1986cited by this paper
• Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity

  1983cited by this paper

• Immunomodulation by 4-Hydroxy-TEMPO (TEMPOL) and Dimethyl Fumarate (DMF) After Ventral Root Crush (VRC) in C57BL/6J Mice: A Flow Cytometry Analysis

  2025cites this paper
• Whole genome sequencing reveals candidate causal genetic variants for spastic syndrome in Holstein cattle

  2024cites this paper
• Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response

  2023cites this paper
• Usefulness and Clinical Impact of Whole-Body MRI in Detecting Autoimmune Neuromuscular Disorders

  2023cites this paper
• Polymyositis, presenting with acute respiratory failure, misdiagnosed as Guillain-Barre syndrome

  2023cites this paper
• About a rare association: Guillain–Barré Syndrome and polymyositis

  2022cites this paper
• Erratum: Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome.

  2019cites this paper
• Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome

  2019cites this paper
• Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System

  2019cites this paper
• 97 – The Respiratory System and Neuromuscular Diseases

  2016cites this paper
• Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome

  2016cites this paper
• Neuromuscular Respiratory Failure

  2014cites this paper
• Rheumatologic Disorders in the PICU

  2014cites this paper
• Antibody-Mediated Rejection of the Heart in the Setting of Autoimmune Demyelinating Polyneuropathy: A Case Report and Review of the Literature

  2012cites this paper
• Utilization of health promotion and wellness services among middle-aged and older adults with multiple sclerosis in the mid-west US.

  2010cites this paper
• Multiple sclerosis and aging: complexities, concerns and considerations for care

  2009cites this paper
• Exploring physical activity behaviour of persons with multiple sclerosis: a qualitative pilot study

  2009cites this paper
• 19 Respiratory Failure

  2009cites this paper
• How citation distortions create unfounded authority: analysis of a citation network

  2009cites this paper
• Neuromuscular Respiratory Failure

  2009cites this paper
• Tratamiento de padecimientos neuromusculares con inmunoglobulina y plasmaféresis

  2009cites this paper
• Running head: PAIN AND DISCOMFORT IN THE MYASTHENIA GRAVIS

  2007cites this paper
• Myasthenia gravis from Thomas Willis to the present.

  2005cites this paper
• Apoptotic responses common to cancer and inflammation

  2004cites this paper
• Endocarditis tricuspídea por Stenotrophomonas maltophilia en un paciente sin factores de riesgo

  2004cites this paper
• Asociación entre dos enfermedades neuromusculares de base inmunológica: esclerosis múltiple y dermatomiositis

  2004cites this paper
• [Association between two immunologic neuromuscular disorders: multiple sclerosis and dermatomyositis].

  2004cites this paper